Tiago Marques, Chief Executive Officer at Pasithea Therapeutics Corp. (KTTA), sold 960 shares at $0.83 ($797) on 2025-05-12, disclosed to the SEC on 2025-05-14.
Open-market sale of $797 KTTA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.